Wockhardt at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

Wockhardt brings 1 presentation to IDWeek 2026 in Washington, and exhibits at Booth 305, 627. Its program centres on Zaynich and a new approach to treating resistant gram-negative infections. It describes the drug as the first of a class called beta-lactam enhancers.

OrganizationIDWeek 2026 Attendance
Wockhardt
Mumbai, India
wockhardt.com
Large pharma
Indian pharmaceutical company developing antibiotics for drug-resistant infections, including Zaynich (cefepime-zidebactam) for resistant gram-negative bacteria.
Booth
Exhibiting at Booth 305, 627
Thu, Oct 2210am–2pmFri, Oct 2310am–2pmSat, Oct 2410am–2pm
Industry
Fri Oct 23
10:15am–11:00am

Explore the full IDWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full IDWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Wockhardt

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction